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ABSTRACT
Objective: The purpose of this study was to determine antihypertensive activity of extract and fractions of matoa (Pometia pinnata) leaves.
Methods: Matoa leaves were extracted by reflux, followed by evaporating using rotary evaporator. Hypertension was induced by 50 mg/kg bw. NaCl 
and 1.5 mg/kg bw. prednisone orally, every day as long as 28 days, then continued over the next 28 days in the therapy period. Male Sprague Dawley 
rats were divided into 12 groups which were hydrochlorothiazide (0.45 mg/kg bw.), control group hypertensive, control normal, matoa leaves extract 
(MLE) (with doses of 50 mg/kg bw., 100 mg/kg bw., and 150 mg/kg bw.), ethylacetate fraction (with doses of 4.35 mg/kg bw., 8.71 mg/kg bw., and 
13.06 mg/kg bw.), and water fraction (with doses of 10 mg/kg bw., 21.88 mg/kg bw., and 32.82 mg/kg bw.). Measurement of systolic and diastolic 
blood pressure was done every weeks using direct tail-cuff of noninvasive method. Then histomorphology of muscle heart was performed at the end 
of this research.
Results: Ethylacetate fraction of matoa leaves 13.08 mg/kg bw. and MLE 150 mg/kg bw. gave significant result in lowering blood pressure (p<0.05) on 
the 28th day of therapy and showed an equal profile with hydrochlorothiazide (0.45 mg/kg bw). Histomorphological result of rat’s muscle heart found 
collagen production was increased in NaCl-prednisone induced rats.
Conclusions: Extract and fractions of P. pinnata leaves could decrease blood pressure of NaCl-prednisone induced hypertension rats, but this effect 
was not liniear with doses and they did not decrease the collagen production in cardiac myocardium compared to normal group.
Keywords: Pometia pinnata, Leaves, Hypertension, Tail-cuff noninvasive method, Blood pressure.
INTRODUCTION
Hypertension is one of the cardiovascular problems which can be 
happened to many people. Hypertension (6.8%) is top three, which 
cause of death after stroke (15.4%) and tuberculosis (7.5%). Based 
on blood pressure measurement was revealed that about 31.7% of 
hypertension happened in Indonesian was around 18-year-old. The 
highest rate of hypertension in Indonesia is in South Kalimantan about 
39.6% of population and West Papua is the lowest rate about 20.1% of 
population. Around 7.2% of health service hypertension was diagnosed 
and 7.6% from interview and only 0.4% of the hypertension patients 
got medications. Therefore, we know, why health service could only 
treated 24.0% out of 31.7% of hypertension problems. It is around 
76.0% of all hypertension cases has not been treated yet [1]. The World 
Health Organization also explained that the percentage of hypertension 
on men (over 25-year-old) is quite larger than women. It is proven that 
32.5% of hypertension happened on men and 29.3% on women [2].
Cardiovascular disease (CVD) is a group of diseases that affect the 
heart and blood vessels. Hypertension is one of cardiometabolic risk 
factors that lead to CVD. Hypertension is increasing in blood pressure, 
a condition when the blood vessels increase at persistent pressure with 
systolic blood pressure greater than or equal to 140 mmHg or diastolic 
blood pressure ≥90 mmHg [2,3].
The use of prednisone and NaCl as an inducer of hypertension has been 
conducted in several studies. Salt retention is characteristic of human 
hypertension and can be achieved rapidly in uninephrectomised rats 
by mineralocorticoid administration, subcutaneous injections as 1% 
NaCl in the drinking water. Corticosterone-induced hypertension, left 
ventricular (LV) fibrosis, and LV diastolic dysfunction. Prednisone is a 
compound of mineralocorticoid. Mineralocorticoids cause retention 
of sodium and water in the body until diuresis occurs due to increase 
pressure on the kidney. No further retention of sodium and water 
occurs, but general sodium and water level in the body is slightly 
increased [4-7].
Physiologically, normal kidney has ability to excrete salt load easily 
without allowing a marked rise in extracellular volume. However, 
general epidemiological data have shown that higher average sodium 
intake in a given population will be greater in the prevalence of 
hypertension. Chronic ingestion of excess salt will show hypertension 
in rats, which mimics human hypertension morphologically [4,8].
Nonpharmacological therapy is an important component in treating 
patients with hypertension. In stage 1 hypertension, blood pressure can 
be adequately controlled by combination of weight loss (in overweight 
individuals), restricting sodium intake, increasing aerobic exercise, and 
moderating consumption of alcohol. It is difficult for many persons to 
implement. The lifestyle changes can facilitate blood pressure control 
in patients, but only lifestyle changes insufficient in hypertension 
patients [9]. It can cause noncompliance in therapy so that a therapeutic 
target is not reached.
Ethanolic leaves, peels and seed extracts of matoa (Pometia pinnata) which 
were given by orally could increase urinary excretion. Study regarding 
relationship between time observation (hours) against the average volume 
of urine for 4 hrs, revealed that all of extracts sample showed diuretic 
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effect. Matoa seed extract with dose of 100 mg/kg bw. showed the highest 
diuretic effect. The diuretic activity of all of treated extracts (except matoa 
seed extract with dose 100 mg/kg bw.) had no significant difference with 
furosemide. Matoa leaves extract (MLE) with dose of 50 mg/kg bw. gave 
the highest sodium levels which were not significantly different compared 
to furosemide, while the other groups had a significant difference with 
furosemide (p<0.05). The potassium levels in all of extracts sample had no 
significant difference with furosemide [10].
Therefore, this is big opportunity to find a new antihypertensive 
medicine which safe, effective, and high quality. The most natural 
source to get a good antihypertensive medicine is from plants. There are 
so many types of plant in Indonesia that have great effect to decrease 
blood pressure and one of them is matoa (P. pinnata), which has been 
used by people in Pajang, Surakarta - Central Java, Indonesia.
METHODS
Materials
Leaves of matoa (P. pinnata), 96% ethanol, n-hexane, hydrochlorothiazide, 
prednisone, sodium chloride, sodium carboxymethylcellulose, distilled 
water, reflux apparatus, rotary evaporator, separatory funnel, and CODA 
Instrument®.
Preparation of sample
Leaves of P. pinnata were collected from Sukoharjo, Central Java, 
Indonesia. Sample was determined in Herbarium Bandungense, School 
of Life Sciences and Technology, Bandung Institute of Technology. 
Sample was thoroughly washed with tap water, sorted while wet, cut, 
dried at 50°C for 5 days, and grinded into powder.
Extraction
Sample was extracted by reflux using 96% ethanol. 500 g of crude drug 
was refluxed with 1.5 L of 96% ethanol for 3 hrs, done triplicate (named 
as MLE). Liquid extract was filtered and then evaporated using rotary 
evaporator at 40°C and speed of 40 rpm.
Fractionation
Extract was fractionated by liquid-liquid extraction (LLE) with 
increasing polarity solvent. Ethanol extract 20 g was added 200 ml of hot 
water then LLE using n-hexane 200 ml. LLE was performed triplicate. 
Furthermore, the residue was LLE with ethyl acetate 200 ml, carried 
out triplicate, and the residue was water fraction. Hence, there were 
three kinds of extracts: N-hexane fraction, matoa ethylacetate fraction 
(MEF), and matoa water fraction (MWF). The obtained fractions were 
concentrated by rotary evaporator.
Hypertension activity
This study used 60 male Sprague Dawley rats weighing between 200 
and 250 g. Rats were weighed and marked, respectively, and were 
randomly divided into 12 groups, each group consisted of 5 rats. The 
groups were MLE with dose of 50 mg/kg bw. (MLE 1), MLE 100 mg/kg 
bw. (MLE 2), MLE 150 mg/kg bw. (MLE 3), MWF 10 mg/kg bw. (MWF 1), 
MWF 21.88 mg/kg bw. (MWF 2), MWF 32.82 mg/kg bw. (MWF 3), MEF 
4.35 mg/kg bw. (MEF 1), MEF 8.71 mg/kg bw. (MEF 2), MEF 13.06 mg/kg 
bw. (MEF 3), hydrochlorothiazide 4.5 mg/kg bw., hypertensive control 
group, and normal group. Previously, rats were fasted for 12 hrs. Before 
treatment, the rats were habituation to experimental tool. Habituation 
is intended that the rats accustomed to a blood pressure tool on direct 
tail-cuff noninvasive (CODA Instrument®). Rat was added restrainer for 
20 cycles (±20 min). Then O-cuff and VPR-cuff from CODA Instrument® 
was attached to the base of the tail to test animals accustomed to 
the pressure of test animals that entered the O-cuff and VPR-cuff. 
Habituation was conducted for two weeks [11].
Hypertension was induced by NaCl 50 mg/kg bw. and prednisone 
1.5 mg/kg bw. orally [12] for 28 days and continued for 28 days of 
therapy. Hydrochlorothiazide (comparator drug), MLE, MWF, and MEF 
were administered on 28 days, and 28 days later of therapy (totally 
56 days). MLE, MWF, MEF, and hydrochlorothiazide were suspended in 
1% CMC-Na, then administered orally to rats.
Observation parameters were systolic and diastolic blood pressure 
of animals. Measurement was conducted using direct method of 
noninvasive tail-cuff by CODA Instrument®. Measurements were 
performed before induction (0 day [T0]), during induction: Induction 
of 7th day (T1), induction of 14th day (T2), induction of 21st day (T3), and 
induction of 28th day (T4) and during therapy: Therapy 7th day (T5), 
therapy 14th day (T6), therapy 21st day (T7), and therapy 28th day (T8). 
The results of each group compared to different condition groups and 
other groups.
Ethics committees
The permission for conduction of these experiments was obtained from 
the relevant Ethics Committees, School of Pharmacy - Bandung Institute 
of Technology.
Statistical analysis
Data were expressed as mean±standard deviation. Statistical analysis 
was performed using one-way analysis of variance followed by post hoc 
Tukey. Significant differences were set at values <0.05.
RESULTS
The treatment of animals began with induction of blood pressure 
for all groups (except the normal control) for 28 days before the 
therapy and continued for 28 days during therapy. Evaluation of 
systolic and diastolic blood pressure of animals was measured 
weekly for 28 days, at T0, T1, T2, T3, and T4. The results can be seen 
in Tables 1 and 2.
Table 1: The systolic blood pressure of hypertensive-induced rats
Group Systolic blood pressure (mmHg)
T0 T1 T2 T3 T4
MLE 1 105.7±22.96 131.26±11.90 136.45±11.90c 137.9±11.88c 112.3±8.44c
MLE 2 108.75±23.14 128.65±11.02 136.4±11.02c 142.35±7.86c 110.5±16.87c
MLE 3 111.2±7.43 132.25±11.99 134.3±11.99c 140.1±19.02c 108.15±14.16c
MWF 1 107.3±18.18 127.6±6.94 135.15±6.94c 147±19.74c 106.8±4.08c
MWF 2 109.5±8.77 128.85±9.80 140.3±9.80c 143±5.52c 109.05±10.69c
MWF 3 108.85±17.56 133.8±11.23c 141.7±11.23c 148.2±19.97c 111.55±14.05c
MEF 1 104.1±5.03 126.75±7.42 139.3±7.42c 144.7±15.30c 113.15±9.76c
MEF 2 110.35±12.20 129.65±4.41 137.7±4.41c 143.75±12.68c 114.7±10.64c
MEF 3 108.9±6.20 131.8±5.20 142.1125±9.81c 149.95±20.53c 117.3±9.37c
HCT 107.2±8.93 136.75±10.94c 144.675±17.68c 145.85±8.97c 113.25±6.94c
Hypertension 108.95±12.71 130.7±4.44 138±2.65c 143.25±5.14c 114.05±14.03c
Control 106.25±6.80 106.85±10.20 104.4±2.55ab 105.25±2.75ab 78.45±8.00ab
aSignificantly different compared to hypertension group (p<0.05), bsignificantly different compared to hydrochlorothiazide (p<0.05), csignificantly different compared to 
control group (p<0.05). MLE: Matoa leaves extract, MWF: Matoa water fraction, MEF: Matoa ethylacetate fraction
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The next treatment was evaluation in lowering of blood pressure of 
the groups and compared to the control group during 28 days after 
the induction period. The evaluation was based on parameters of 
systolic and diastolic blood pressure of rats and measured weekly 
for 28 days, at 7th day therapy (T5), 14th day therapy (T6), 21st day 
therapy (T7), and 28th day therapy (T8). The results can be seen in 
Tables 3 and 4.
Histomorphology observations of heart muscle of rats can be seen in 
Figs. 1-4.
DISCUSSION
Antihypertensive activity test of extract and fractions of matoa leaves 
were conducted on male Sprague Dawley strain rats. Hypertension 
was induced using NaCl 50 mg/kg bw. and prednisone of 1.5 mg/kg 
bw. orally, every day as long as 28 days. Mineralocorticoids cause 
retention of sodium and water in the body until diuresis occurs due to 
increase pressure on the kidneys. No further retention of sodium and 
water occurs, but general level of body sodium and water is slightly 
raised [4].
Table 2: The diastolic blood pressure of hypertensive-induced rats
Groups Diastolic blood pressure (mmHg)
T0 T1 T2 T3 T4
MLE 1 76.2±5.57 83.575±10.98 88.45±16.68 110.65±3.42c 112.3±8.44c
MLE 2 75.2±9.88 87.85±8.82 92.15±17.53 110.1±8.09c 110.5±16.87c
MLE 3 74.55±6.70 90.15±17.3 103.1±17.19 107±12.04c 108.15±14.16c
MWF 1 70.02±6.72 94.2±7.43 97.2±19.16 105.8±11.33c 106.8±4.08c
MWF 2 74.6±11.07 84.4±15.28 101.55±16.32 109.6±3.04c 109.05±10.69c
MWF 3 75.4±22.73 85,8±14.81 104.15±15.13 108.75±2.02c 111.55±14.05c
MEF 1 75.9±13.97 99.45±14.70 101.45±24.21 110.45±15.70c 113.15±9.76c
MEF 2 72.4±8.24 87.5±10.21 111.45±11.97 112.4±2.97c 114.7±10.64c
MEF 3 75.35±9.71 90.85±6.94 112.28±17.32 116.45±12.22c 117.3±9.37c
HCT 75.6±11.03 92.45±6.36 99.32±21.12 109.7±4.19c 113.25±6.94c
Hypertension 74±2.72 89.35±9.89 106.2±11.45 111.25±11.03c 114.05±14.03c
Control 76,75±10.53 81,55±6.72 79.35±5.30 82±4.83ab 78.45±8.00ab
aSignificantly different compared to hypertension group (p<0.05), bsignificantly different compared to hydrochlorothiazide (p<0.05), csignificantly different compared to 
control group (p<0.05). MLE: Matoa leaves extract, MWF: Matoa water fraction, MEF: Matoa ethylacetate fraction
Table 3: The systolic blood pressure during therapy
Group Systolic blood pressure (mmHg)
T4 T5 T6 T7 T8
MLE 1 149.60±15.94c 136.8±9.04 134.15±9.11 112.95±19.19a 109.375±17.67a
MLE 2 150.35±18.52c 139.6±11.35c 130.85±12.86 128.2±10.47 113.95±11.36a
MLE 3 145.8±8.24c 143.15±13.92c 138.3±24.82 129.86±10.87 103.965±4.44a
MWF 1 149.05±11.40c 135.05±8.44b 135.45±10.43 131.55±10.06 126.8±4.89abc
MWF 2 148.5±14.33c 141±6.93c 140.15±18.81c 129.65±22.07 124.75±3.30abc
MWF 3 149.47±9.46c 142.5±4.04c 139.05±9.19 131.35±16.22 120.1±5.95a
MEF 1 151,4±9.82c 132.85±11.61c 128.55±1.32 124.6±2.67 113.45±8.40a
MEF 2 147.73±8.29c 130.2±3.12c 129.45±9.12 120.75±6.72 109.7±19.76a
MEF 3 151.1±7.86c 143.4±9.78bc 129.7±21.31 119.6±13.08a 102.95±4.47a
HCT 149.15±9.87c 120.1±7.5a 115.8±10.61 109.92±7.90a 101.25±4.06a
Hypertension 148.6±7.51c 148±10.70bc 149.17±16.69c 151.1±13.98bc 155±2.44bc
Control 103.7±5.92ab 104.6±6.08 105±4.32a 103.4±4.55a 101.1±3.03a
aSignificantly different compared to hypertension group (p<0.05), bsignificantly different compared to hydrochlorothiazide (p<0.05), csignificantly different compared to 
control group (p<0.05). MLE: Matoa leaves extract, MWF: Matoa water fraction, MEF: Matoa ethylacetate fraction
Table 4: The diastolic blood pressure during therapy
Group Diastolic blood pressure (mmHg)
T4 T5 T6 T7 T8
MLE 1 112.3±8.44c 112.25±23.92c 94.6±10.1 91.55±15.70 85.53±4.92
MLE 2 110.5±16.87c 110.1±8.23c 101.1±5.75 95.25±13.63 84.55±2.74a
MLE 3 108.15±14.16c 107.55±3.25c 98.35±23.71 93.2±11.88 82.26±3.4a
MWF 1 106.8±4.08c 105±3.66c 100.55±20.70 98.8±13.93 97.25±7.66
MWF 2 109.05±10.69c 103.6±13.99c 104.35±8.73c 100.05±23.44 94±6.68
MWF 3 111.55±14.05c 109.5±7.97c 109.55±7.75c 105.6±18.05 102.2±22.59
MEF 1 113.15±9.76c 110.85±8.81c 93.8±20.87 97.1±12.56 92.35±17.67
MEF 2 114.7±10.64c 113.5±3.10c 86.5±1.11 86.45±6.86 83.65±26.70a
MEF 3 117.3±9.37c 114.55±15.85c 100.4±7.28 91.9±9.25 82.6±4.94a
HCT 113.25±6.94c 99.45±11.36 87.9±6.27c 84.35±13.30 83.35±15.87a
Hipertension 114.05±14.03c 114.5±5.19c 115.66±6.23c 115.95±4.22bc 116.75±0.95bc
Control 78.45±8.00ab 72.2±8.05a 74.75±13.59a 76.5±11.67a 74.2±5.71a
aSignificantly different compared to hypertension group (p<0.05), bsignificantly different compared to hydrochlorothiazide (p<0.05), csignificantly different compared to 
control group (p<0.05). MLE: Matoa leaves extract, MWF: Matoa water fraction, MEF: Matoa ethylacetate fraction
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Male Sprague Dawley rats were divided into 12 groups which were 
hydrochlorothiazide (0.45 mg/kg bw.), control hypertensive, control 
normal, MLE (with doses of 50 mg/kg bw., 100 mg/kg bw., 150 mg/kg 
bw.), ethylacetate fraction (with doses of 4.35 mg/kg bw., 8.71 mg/kg 
bw., 13.06 mg/kg bw.), and water fraction (with dose of 10 mg/kg bw., 
21.88 mg/kg bw., 32.82 mg/kg bw.).
In pharmacological experiments to determine the pharmacological 
activity using animal model, there are several steps that must be met. 
Before animal treatment in this study, acclimatization to the laboratory 
conditions and habituation with blood pressure tool on tail-cuff 
noninvasive CODA Instrument® were conducted for 2 weeks. It was 
done so that the animals get habitual with the laboratory conditions 
and tools that do not affect the measurement data. The average of 
normal systolic blood pressure at 0 day (T0) was 108.09 ± 2.03 mmHg 
(p=1.00) and diastolic blood pressure was 74.66 ± 1.84 mmHg 
(p=1.00) with 95 % degree of confidence, then analysis was continued 
by parametric test.
The increasing in blood pressure induction of all groups was compared 
to control group. This phase aimed to test the ability of NaCl and 
prednisone to increase blood pressure, by analyzing systolic and 
diastolic blood pressure every week, started at 0 day (T0) until 28th day 
(T4) induction period, showed that there were no significant difference 
between systolic and diastolic blood pressure of all groups which were 
induced by NaCl and prednisone on day 28 of induction (T4) (Tables 1 
and 2). Based on the obtained results, it can be concluded that induction 
by NaCl and prednisone for 28 days, increased the systolic and diastolic 
blood pressure on male Sprague Dawley strain rats significantly 
compared to the control group (p<0.05).
Fig. 1: The cross-section of heart muscle histology on ×40 magnification, the collagen green transparent with Masson’s trichrome staining. 
(a) Control, (b) hypertension, (c) matoa water fraction 2
cba
Fig. 2: The cross-section of heart muscle histology on ×100 magnification, the collagen green transparent with Masson’s trichrome 
staining. (a) Control, (b) hypertension, (c) matoa water fraction 2
cba
Fig. 3: The cross-section of heart muscle histology on ×400 magnification, the collagen green transparent with Masson’s trichrome 
staining. (a) Control, (b) hypertension, (c) matoa water fraction 2
cba
Fig. 4: The cross-section of heart muscle histology on ×1000 magnification, the collagen green transparent with Masson’s trichrome 
staining. (a) Control, (b) hypertension, (c) matoa water fraction 2
cba
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The next evaluation was to measure blood pressure during therapy. 
The results in lowering blood pressure during therapy treatment were 
compared to hypertension group and control group. The aim of this 
phase was to test the ability of sample in delivering antihypertensive 
effect. Comparison between hydrochlorothiazide 0.45 mg/kg bw. and 
control group was aimed to validate the testing method in decreasing 
in blood pressure of test animals. Based on the analysis of systolic and 
diastolic blood pressure every week, started at 0th day (T4) until 28th day 
duration of therapy (T8), demonstrated that there were significant 
difference between systolic (at T5 until T8) and diastolic (beginning at 
the 28th day of therapy T8) of hydrochlorothiazide group compared to 
hypertension group (p<0.05).
In addition, comparison between hydrochlorothiazide to control group 
was also to see the effectiveness of hydrochlorothiazide in lowering in 
blood pressure to reach normal. There were no significant difference 
in systolic blood pressure (started at T5) and diastolic (started at T5) 
between hydrochlorothiazide to control group. It can be concluded that 
hydrochlorothiazide was effective to decrease blood pressure closed to 
normal, started at T5 (at 7th day therapy).
The comparison between hypertension group and control group was 
carried out by analyzing the systolic and diastolic blood pressure every 
week started at 0th day (T4) until 28th day (T8) during the therapy. 
There was significantly different in systolic and diastolic blood pressure 
of hypertension group and control group during the treatment period 
(p<0.05). It can be concluded that NaCl 50 mg/kg bw. and prednisone 
1.5 mg/kg bw. which were administered orally and then continued 
for 28 days of therapy was able to keep significantly different blood 
pressure compared to hypertension group (p<0.05).
The next step was to compare sample groups (MLE 1, MLE 2, MLE 3, 
MWF 1, MWF 2, MWF 3, MEF 1, MEF 2, and MEF 3) and hypertension 
group, to test the ability antihypertensive effect of sample groups. 
Based on the analysis of systolic blood pressure weekly during 
the treatment (T5 until T8), it can be seen there were significant 
difference between MLE 1, MLE 2, MLE 3, MWF1, MWF 2, MWF 3, 
MEF 1, MEF 2, and MEF 3 compared to hypertension group at T8 
(p<0.05), while the MLE 1 and MEF 3 groups started at T7 (Table 3). 
Diastolic blood pressure started giving significantly decrease at 
T8 (28th day of therapy) in MLE 2, MLE 3, MEF 2, and MEF 3 compared 
to hypertension group (p<0.05). It can be concluded that the MEF 2 
gave significantly decrease (p<0.05) compared to hypertension group 
started from 21th day until the end of therapy, while MLE 2, MLE 3 and 
MEF 3 started from 28st day.
The sample was also compared to control group to test the ability of 
sample to provide antihypertensive effect to normal blood pressure. 
Based on statistical analysis every week started at 0th day (T4) until 
28th day (T8) therapy, the results denoted that systolic blood pressure 
of all sample groups was not significantly different with the control 
group started at 14th day (T6) to 28th day (T8) therapy (except systolic 
of MWF 2 at T6), while diastolic blood pressure of all sample groups 
gave no significant difference with control started at 14st day (T6) 
(except MWF 2 and MWF 3 until 28th day (T8).
Furthermore, the comparison between sample group and 
hydrochlorothiazide group to prove the effectiveness of 
antihypertensive effect of sample. It can be seen in Tables 3 and 4, 
there was no significant difference between sample groups and 
hydrochlorothiazide group (except systolic of MWF 1 at T5 and MEF 1 
and MEF 2 at T8).
Research by Joshi resulted that extract of Evolvulus alsinoides herb 
in adrenaline-induced hypertensive rats was significantly decreased 
compared to control hypertensive group [13]. Previous study by 
Alamgeer et al. [14] exposed that aqueous methanol extract of 
Caralluma tuberculata possessed antihypertensive activity in rats 
which was hypertension with egg-fed and glucose induced.
Research by Jena resulted that a rise in blood pressure was found on 
day 16th on fructose-induced hypertension rats. Ethanolic extract of 
Eclipta alba decreased the rise in blood pressure significantly in a dose-
dependent manner comparable to quinapril [15].
Based on the results of histological observation, there was increasing 
in spread of collagen in heart muscle of hypertensive rat which induced 
by NaCl-prednisone. The heart muscle in hypertensive rats was damage 
compared to control group which its muscle fiber was still good. This 
damage can indicate myocardial fibrosis. Mohanty et al. [16] stated 
that the chronic administration of prednisone could increase the risk 
of cardiac perivascular fibrosis. Myocardium on hydrochlorothiazide 
group was better than the hypertension group. In contrast with calcium 
channel blocker agent, the antihypertensive effect of diuretic such as 
hydrochlorothiazide may be due to chronic sodium depletion which 
resulted decreasing in responsiveness of the efferent sympathetic 
nervous system or modification of the affinity of arterial smooth muscle 
receptors for angiotensin and norepinephrine [16].
Angiotensin receptor blocker will inhibit the synthesis of collagen 
type 1 in patients with hypertension [17]. Therefore, the thiazides will 
inhibit stimulation of fibroblasts to produce collagen. On the other 
hand, the extract and fractions of matoa (P. pinnata) leaves were not 
able to repair damage the heart muscle caused by hypertension.
The previous study demonstrated analysis of collagen levels using image 
analyzer. The ImageJ software did not show a significant difference 
between the test groups compared to positive and negative ones. Based 
on these images, it could be seen that the collagen network which was 
formed in positive control group and the test group (captopril, losartan, 
and amlodipine) higher than the negative control group. Increasing in 
blood pressure could increase synthesis of collagen in heart and also 
cardiac collagen [18].
CONCLUSION
Extract and fractions of P. pinnata leaves could decrease blood pressure 
of NaCl-prednisone induced hypertension rat. The effect was not liniear 
with dosage and they did not decrease the collagen production in 
cardiac myocardium.
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